News

Proteins are the infinitely varied chemicals that make cells work, and science has a pretty good idea how they are made. But ...
Your morning coffee may offer more than just a quick jolt of alertness. New research from Queen Mary University of London ...
This developmental transition is accompanied by cell cycle adaptation, such as lengthening or shortening of the gap phases G1 and G2. However, regulation of these cell cycle changes is poorly ...
Caffeine appears to affect how cells handle stress and DNA damage—but researchers say it’s no magic bullet. Here’s what the ...
The official results of the BRACELET-01 (PrECOG 0113) trial have been published in Clinical Cancer Research, detailing the safety and efficacy of ...
We define a sleeper cell as a covert group that remains inactive until ordered to strike, posing a latent threat to national ...
AbstractImmune checkpoint blockade (ICB) has revolutionized cancer treatment. Unfortunately, the inability of lymphocytes to infiltrate the tumor nest, a phenomenon known as immune exclusion, ...
AbstractImmune checkpoint blockers (ICB) targeting the PD-1/PD-L1 axis represent established therapies for many cancers. However, resistance occurs in most patients due to complex immune-suppressive ...
Citius Oncology has completed commercial-scale manufacturing of LYMPHIR, with packaged and labeled inventory now held at a leading global Contract Development and Manufacturing Organization (CDMO).
Three Prime Repair Exonuclease 1 (TREX1) is the most abundant 3′ exonuclease in human cells, playing a pivotal and complex role in both autoimmune regulation and cancer immunity. Despite its ...
Incyte (Nasdaq:INCY) today announced that primary results from the Phase 3 POD1UM-303/InterAACT 2 trial of retifanlimab (Zynyz ®), a humanized monoclonal antibody targeting programmed death receptor-1 ...
Background: Immune checkpoint inhibitors (ICIs) have emerged as a promising treatment option for advanced non-small-cell lung cancer (NSCLC) patients, highlighting the need for biomarkers to identify ...